GlassScriptPhysician profile
Allison Mae Moss
NPI 1699241950
$1,335.16
in general payments reported to CMS, 2019-2025
19 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $164 · 2022: $59.80 · 2023: $326 · 2024: $415 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $290.99 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $263.94 | 2023-2025 | |
| Lilly USA, LLC | $134.64 | 2023-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $84.64 | 2023-2024 | |
| Glaxosmithkline, LLC. | $79.81 | 2022-2023 | Trelegy Ellipta |
| Exact Sciences Corporation | $69.81 | 2025 | The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $61.89 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $61.68 | 2023-2024 | Caplyta |
| Biohaven Pharmaceuticals, INC. | $37.87 | 2021 | |
| Amgen INC. | $36.20 | 2024-2025 | Evenity, Prolia |
| Phathom Pharmaceuticals, INC. | $35.09 | 2025 | Voquezna |
| Dexcom, INC. | $34.46 | 2021-2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.39 | 2023 | Tradjenta, Synjardy |
| Merck Sharp & Dohme LLC | $29.41 | 2023-2024 | Gardasil 9, Capvaxive, Gardasil |
| Alnylam Pharmaceuticals INC. | $24.95 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $19.27 | 2025 | |
| Sanofi Pasteur INC. | $15.04 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.25 | 2023 | Breztri |
| Amarin Pharma, INC. | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.